INS and diabetes mellitus: It includes four risk factors: pre-op number of diabetes medications, pre-op insulin use, pre-op duration of diabetes (years), pre-op glycemic control (<7%) and T2DM remission rate is expected to be higher after metabolic surgery in patient with mild severity [61,62].